integMET
Home
About
Documentation
Diff Profiles
Metabolites
studies
Gragh
Metabolites
›
UEFRDQSMQXDWTO-GKAPJAKFSA-N
UEFRDQSMQXDWTO-GKAPJAKFSA-N
UEFRDQSMQXDWTO-GKAPJAKFSA-N
0 Reactome links
2 studies
2
Observed studies
2
Observed diff profiles
0
Reactome pathways
Metabolite details
Identifier
UEFRDQSMQXDWTO-GKAPJAKFSA-N
InChI Key
UEFRDQSMQXDWTO-GKAPJAKFSA-N
IUPAC name
Preferred name
UEFRDQSMQXDWTO-GKAPJAKFSA-N
INN name
—
Synonym
—
ChEBI
—
Reactome pathways
No Reactome pathways listed for this metabolite.
Observed in studies
Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
Observed in differential profiles
G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
Control_vs_OXPA_Treatment